<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Reversible transition from a hypertrophic to a dilated cardiomyopathy</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-12-09">9 December 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Frank</forename><surname>Spillmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité-University Medicine of Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Uwe</forename><surname>Kühl</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité-University Medicine of Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sophie</forename><surname>Van Linthout</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<orgName type="institution">Charité-University Medicine of Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Deutsches Zentrum für Herz-Kreislaufforschung (DZHK)-Standort Berlin/Charité</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fernando</forename><surname>Dominguez</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Hospital Universitario Puerta de Hierro</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Felicitas</forename><surname>Escher</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité-University Medicine of Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">IKDT-Institut kardiale Diagnostik und Therapie GmbH</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heinz-Peter</forename><surname>Schultheiss</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">IKDT-Institut kardiale Diagnostik und Therapie GmbH</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Burkert</forename><surname>Pieske</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité-University Medicine of Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Deutsches Zentrum für Herz-Kreislaufforschung (DZHK)-Standort Berlin/Charité</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Cardiology</orgName>
								<orgName type="department" key="dep2">Deutsches Herzzentrum Berlin (DHZB)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Carsten</forename><surname>Tschöpe</surname></persName>
							<email>carsten.tschoepe@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité-University Medicine of Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<orgName type="institution">Charité-University Medicine of Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Deutsches Zentrum für Herz-Kreislaufforschung (DZHK)-Standort Berlin/Charité</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum, Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Reversible transition from a hypertrophic to a dilated cardiomyopathy</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-12-09">9 December 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">68258B3898E76A2ABDAA232C51C4BB9E</idno>
					<idno type="DOI">10.1002/ehf2.12072</idno>
					<note type="submission">Received: 07 August 2015; Revised: 10 September 2015; Accepted: 01 October 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:41+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Dilated cardiomyopathy</term>
					<term>Hypertrophic cardiomyopathy</term>
					<term>Transition of cardiomyopathy</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We report the case of a 17-year-old female patient with known hypertrophic cardiomyopathy and a Wolff-Parkinson-White syndrome.</s><s>She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fraction.</s><s>Clinically, she complained about atypical chest pain, arrhythmic episodes with presyncopal events, and dyspnea (NYHA III) during the last 6 months.</s><s>Non-invasive and invasive examinations including magnetic resonance imaging, electrophysiological examinations, and angiography did not lead to a conclusive diagnosis.</s><s>Therefore, endomyocardial biopsies (EMBs) were taken to investigate whether a specific myocardial disease caused the impairment of the left ventricular function.</s><s>EMB analysis resulted in the diagnosis of a virus-negative, active myocarditis.</s><s>Based on this diagnosis, an immunosuppressive treatment with prednisolone and azathioprine was started, which led to an improvement of cardiac function and symptoms within 3 months after initiating therapy.</s><s>In conclusion, we show that external stress triggered by myocarditis can induce a reversible transition from a hypertrophic cardiomyopathy to a dilated cardiomyopathy phenotype.</s><s>This case strongly underlines the need for a thorough and invasive examination of heart failure of unknown causes, including EMB investigations as recommend by the actual ESC position statement.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in young patients.</s><s>The progression of the disease is variable and heterogeneous.</s><s>Whereas especially patients with a non-obstructive form of HCM are thought to stay stable for a long time; a small distinct subset of patients can develop end stage heart failure, which includes a reduction of systolic function and a transition from a former HCM-phenotype to a dilated phenotype. <ref type="bibr" target="#b0">1</ref></s><s>Several mechanisms underlying this transition are discussed and may include specific genetic backgrounds and micro-ischemiainduced damages.</s><s>Reverse remodelling is under these rare circumstances.</s><s>In addition, temporary progression of the disease can be induced because of not primarily cardiac-dependent stress factors.</s><s>Therefore, the differential diagnosis of the socalled 'end stage' HCM is important not to overlook specific treatment options.</s></p><p><s>We report here a case from a young HCM patient where cardiac inflammatory but not primarily HCM-dependent processes induced a decompensating dilated cardiomyopathy (DCM)-like phenotype and show that an anti-inflammatory treatment led to a reverse remodelling under these conditions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Case report</head><p><s>We report about a 17-year-old woman with known HCM without left ventricular (LV) outflow obstruction characterized by a concentric hypertrophy (anterior-septal wall measured 15 mm, posterior 16 mm), preserved LV ejection fraction (EF), and a Wolff-Parkinson-White (WPW) syndrome for which the patient was already ablated twice in her childhood.</s></p><p><s>She was submitted to our department for evaluation of a progression of heart failure, indicated by a new diagnosed drop of the LV-EF to 40%, hypokinesia of the apical and inferior wall, an increase in LV diameters (LV end diastolic diameter (LVEDD): 59 mm; mitral valve-septum: 18 mm), increased filling pressures, and a mitral regurgitation grade II.</s><s>Holter electrocardiogram examinations showed high numbers of ventricular and supraventricular episodes.</s><s>Clinically, she complained of chest pain, dyspnea already at rest (NYHA III), and paroxysmal palpitations with presyncopal events during the past 6 months.</s><s>Blood analysis showed increased N-terminal pro-brain natriuretic peptide (NT-pBNP) levels of 5201 pg/mL and slightly increased transaminases (ALT 40 U/L, AST 60 U/L), without changes in TNT, hsCRP, or leukocyte numbers.</s><s>Over the following 7 days, LV-EF dropped to 20%, indicating a rapid progression of heart failure.</s></p><p><s>Based on these findings, we discussed at least four possible differential diagnosis: (1) tachycardia-induced cardiomyopathy (CM), (2) progression of HCM including (micro) angiopathy-induced changes, (3) development of a severe primary mitral valve regurgitation, and (4) another undetected acquired form of CM.</s><s>In an invasive electrophysiological evaluation, no malignant heart rhythm disturbances were inducible.</s><s>We found a sufficient working atrioventricular node without any signs of accessory bundles excluding a WPW-syndrome induced tachycardiomyopathy.</s><s>Transesophageal echocardiography excluded a primary mitral valve regurgitation.</s><s>For further evaluation of the myocardial structure, we performed cardiac magnetic resonance imaging (MRI).</s><s>The MRI showed a significant hypertrophic and dilated LV (LV diastolic volume of 286 mL) with a further reduced LV-EF (17%).</s><s>There was a pronounced signal of late gadolinium enhancement (LGE) sequences of myocardial necrosis (scar) and/or fibrosis to detect, especially in the septum, apical and lateral part of the LV (reticular delayed enhancement) (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>Further on, there were no signals of myocardial inflammatory processes in the T1-weighted and T2-weighted images detected.</s><s>To investigate whether or not a primarily HCM-dependent progression of the disease or other etiologies were responsible for these findings, we evaluated right ventricular endomyocardial biopsies (EMBs) after exclusion of coronary abnormalities.</s><s>Histological characterization of the EMBs demonstrated perivascular and interstitial fibrosis and significant hypertrophy of myocytes indicated by diameters up to 31 μm.</s><s>A HCM-typical disarray was not detected.</s><s>Similar, no signs of cardiac storage diseases were found using different staining techniques.</s><s>However, immunohistochemical staining showed an extensive active inflammation response of the myocardium (Figure <ref type="figure" target="#fig_1">2</ref>): highly increased β2-leukocyteintegrins/infiltrates (LFA-1/CD11a+ and Mac-1/CD11b+) and mixed cellular infiltrates of both lymphocytes and macrophages (CD45RO-positive and HLA-positive cells) (Table <ref type="table" target="#tab_0">1</ref>). <ref type="bibr" target="#b1">2</ref> Molecular biological analyses by nested polymerase chain reaction excluded the presence of known cardiotropic viruses including enterovirus, adenovirus, Epstein-Barr-virus, human herpesvirus 6, and parvovirus B19. <ref type="bibr" target="#b2">3</ref> Based on the EMB results, which evidenced a virus-negative active myocarditis, which was most probably the cause of the impairment of cardiac function, we initiated an immunosuppressive therapy with corticosteroid (Prednisolone 1 mg/kg/ day) and azathioprine (100 mg/day) under blood count control and liver/kidney function control.</s><s>After 4 weeks, the dose of prednisolone was tapered off every 4 weeks by 10 mg until a maintenance dose of 10 mg was reached. <ref type="bibr" target="#b1">2</ref> Within the time frame of 3 months after starting the immunosuppressive treatment, the LV-EF continuously improved up to 52%, and the LVEDD decreased to 56 mm.</s><s>Also, NT-proBNP levels dropped to 968 pg/mL accompanied by regular levels of transaminases, CRP, and leukocytes.</s><s>In addition, her clinical symptoms improved.</s></p><p><s>In summary, we show that external stress triggered by myocarditis can induce a transition from a HCM-phenotype to a dilated CM (DCM)-phenotype.</s><s>Specific anti-inflammatory treatment strategies after diagnosis by performing EMBs could reverse this transition.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Hypertrophic cardiomyopathy generally underlies a genetic disorder: around 40-60% of all causes of HCM account for gene mutations of cardiac sarcomere proteins (e.g.</s><s>myosinbinding protein C, ß-myosin heavy chain, cardiac troponin I and T, myosin light chain 3 and tropomyosin α-1 chain).</s><s>Especially in infants and adolescents with isolated cardiac hypertrophy, more than 50% of all cases are due to genetic disorders. <ref type="bibr" target="#b3">4</ref></s><s>In addition, mixed genetic disorders causing HCM and rhythm diseases are also known and include the so-called PRKAG2 cardiac syndrome defined by the presence of HCM, ventricular pre-excitation and tachyarrhythmia (WPW-syndrome), and progressive conduction system disease. <ref type="bibr" target="#b4">5</ref></s><s>]<ref type="bibr" target="#b9">[9]</ref><ref type="bibr" target="#b10">[10]</ref> However, the presence of a PRKAG2 syndrome in our patient was already excluded years ago.</s><s>In addition, the evaluation of other well-known mutations able to cause HCM, including the screening for mutations of MYH7, MYBPC3, TNNT2, TPM1, TNNI3, MYL3, MYL2, CSRP3, PLN, ACTC, and TNNC1 did not lead to a definite result in our patient.</s><s>It is well accepted that in up to 30% of HCM, specific mutations cannot be detected or are still unknown.</s><s>In addition, up to 20% of patients with Transition in cardiomyopathy the phenotype of a significant LV hypertrophy do not belong to the classical form of HCM and comprise other genetic and non-genetic causes including storage diseases. <ref type="bibr" target="#b11">11,</ref><ref type="bibr" target="#b13">12</ref></s><s>orms of HCM can develop a DCM-phenotype under stress conditions, but this is not very common and mostly seen in severe forms of HCM with LV obstructions.</s><s>Additional external stress includes emotional stress, toxic substances like alcohol or chemotherapeutics, pregnancy, ischemia, tachycardia-induced heart rhythm disturbances, and inflammation.</s><s>Matsumori et al. reported that viral myocardial infection can belong to these risk factors, too. <ref type="bibr" target="#b14">13</ref></s><s>The myocardial virus itself as well as inflammatory responses can lead to a deterioration of the HCM leading together with an increased intraventricular pressure to a LV dilatation. <ref type="bibr" target="#b15">14</ref></s><s>This mechanism has been described in patients with HCM and myocarditis most likely belonging to the worsening of cardiac function and to the induction of electrical imbalances. <ref type="bibr" target="#b16">15</ref></s><s>ased on the EMB findings, we concluded that our patient suffered from a virus-negative active myocarditis.</s><s>Thus, immunohistochemical analyses evidenced a significant, partly confluent lymphocyte infiltration, and increased expression of adhesion molecules.</s><s>It also showed a marked infiltrate of macrophages and other inflammatory cells, but no increased specific cytotoxic T lymphocytes (perforin positive) were found.</s><s>In opposite to the EMBs, the cardiac MRI did not show specific signs for cardiac inflammatory processes.</s><s>The MRI resulted in the detection of fibrosis (LGE), which could belong to the HCM phenotype or to an additional inflammatory-induced damage.</s><s>Fibrosis could be detected in EMBs taken from the LGE-areas of the septum, too (Figure <ref type="figure" target="#fig_0">1B</ref>).</s><s>However, only the further staining for inflammatory cells of these EMBs led to the definite diagnosis of a severe virus-negative active myocarditis (Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>These results are in agreement with the findings of others showing that cardiac MRI sensitivity (76%), specificity (54%), and accuracy (68%) has important limitations for detection of inflammatory processes and might not be sufficient to diagnose myocarditis in all cases. <ref type="bibr" target="#b17">16</ref></s><s>A negative MRI-result does not automatically exclude a myocarditis and need further evaluation by EMB, as concluded by the ESC working group on myocardial and pericardial diseases. <ref type="bibr" target="#b19">17</ref></s><s>he EMB-based diagnosis of a severe virus-negative active myocarditis led us immediately to start with an immunosuppressive treatment including prednisolone and azathioprine for 6 months as recommended by Caforio et al. <ref type="bibr" target="#b19">17</ref> In accordance to the TIMIC study, <ref type="bibr" target="#b20">18</ref> we evidenced an improvement in LV-EF and a reduction in LVEDD already 3 months after immunosuppressive treatment, correlating with a clinical improvement in NYHA classification (from class III to I).</s></p><p><s>In conclusion, this case shows that myocardial inflammation can contribute to a transition of a hypertrophic to a dilated phenotype, which can be reversible after induction of a specific anti-inflammatory therapy.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p><s>Figure 1 Magnetic resonance images of the heart and histological/immunohistochemical staining for fibrosis and inflammation.</s><s>Representative pictures showing A) Four chamber view and C) short-axis view of T1-weighted magnetic resonance imaging scan.</s><s>B) Four chamber view of a pronounced positive late gadolinium enhancement-magnetic resonance imaging scan.</s><s>Left corner: representative Azan-Mallory staining image for fibrosis (original magnification ×100), right corner: representative LFA-1/CD11a+Àstaining image for cellular infiltration (original magnification ×200) from the septum of the right ventricle and D) short axis view of B.</s></p></div></figDesc><graphic coords="3,140.35,124.95,313.24,288.37" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2 Immunohistological staining of inflammatory cells of right ventricular septal biopsies.</s><s>Representative images depicting A) Mac-1/CD11b+=innfiltrates (original magnification ×200); B) LFA-1/CD11a+=infiltrates (original magnification ×200); C) CD45RO cellular infiltrates (original magnification ×200); and D) HLA cellular infiltrates (original magnification ×100) present in the endomyocardial biopsy.</s></p></div></figDesc><graphic coords="4,127.30,105.93,339.64,269.32" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Quantification of active inflammation in endomyocardial biopsiesHLA and CAM-Expression [AF (%)]Infiltration of immunocompetent cells [cells/mm</s></p></div></figDesc><table><row><cell>2 ]</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">ESC Heart Failure 2016; 3: 138-142 DOI: 10.1002/ehf2.12072</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Spirito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Maron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Zenovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Formisano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lesser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mackey-Bojack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Manning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Udelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Maron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="216" to="225" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Phenotypic characterization of infiltrates in dilated cardiomyopathydiagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Noutsias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pauschinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Schultheiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kühl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Sci Monit</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="R478" to="R487" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">High prevalence of viral genomes and multiple viral infections in the myocardium of adults with &quot;idiopathic&quot; left ventricular dysfunction</title>
		<author>
			<persName><forename type="first">U</forename><surname>Kühl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pauschinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Noutsias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Seeberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lassner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Poller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kandolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Schultheiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="887" to="893" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Shared genetic causes of cardiac hypertrophy in children and adults</title>
		<author>
			<persName><forename type="first">H</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Menesses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mcdonough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kucherlapati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Towbin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Seidman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="page" from="1899" to="1908" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Familial cardiomyopathy: a new autosomal dominant form (abstract)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Cherry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Invest Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">B31</biblScope>
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Gollob</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Soc Trans</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="228" to="231" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>Pt 1</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Arad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sanbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Toka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Konno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Morley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Robbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Seidman</surname></persName>
		</author>
		<imprint>
			<publisher>Seidman</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations</title>
		<author>
			<persName><surname>Ce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Berul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="144" to="154" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMPactivated protein kinase</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">O</forename><surname>Akman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Sampayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Benson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bruno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shanske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Hardie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dimauro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Res</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="499" to="504" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency</title>
		<author>
			<persName><forename type="first">B</forename><surname>Burwinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Buhrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Van Landeghem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Hardie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Kilimann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="1034" to="1049" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Complete genomic structure and mutational spectrum of PHKA2 in patients with X-linked liver glycogenosis type I and II</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hendrickx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Keating</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Carton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Sardharwalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tuchman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Baussan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Willems</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1541" to="1549" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Authors/Task Force members. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the element of hypertrophic cardiomyopathy of the</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Anastasakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Borger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Borggrefe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cecchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Charron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Hagege</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lafont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Limongelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mahrholdt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mogensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nihoyannopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nistri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pieper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Society of Cardiology</title>
		<imprint>
			<publisher>ESC</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2733" to="2779" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Glycogen storage diseases presenting as hypertrophic cardiomyopathy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Arad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Maron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gorham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Johnson</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Saul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Perez-Atayde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Spirito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kanter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Seidman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">352</biblScope>
			<biblScope unit="page" from="362" to="372" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Matsumori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Matoba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nishio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shioi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sasayama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">222</biblScope>
			<biblScope unit="page" from="678" to="682" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration</title>
		<author>
			<persName><forename type="first">A</forename><surname>Frustaci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Verardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Caldarulo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Acconcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chimenti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="733" to="740" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias</title>
		<author>
			<persName><forename type="first">C</forename><surname>Chimenti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Calabrese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thiene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pieroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maseri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Frustaci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="168" to="173" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Lurz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Eitel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Adam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grothoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Desch</surname></persName>
		</author>
		<imprint>
			<pubPlace>Fuernau G, de</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Waha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sareban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Luecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klingel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kandolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gutberlet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thiele</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc Imaging</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="513" to="524" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Caforio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pankuweit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Arbustini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Basso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gimeno-Blanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Felix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Heliö</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heymans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jahns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klingel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Linhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Maisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mogensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ristic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Schultheiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Seggewiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tavazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thiene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yilmaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Charron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Elliott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="2636" to="2648" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Frustaci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chimenti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1995" to="2002" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
